The Phase IIa trial is a randomized, placebo-controlled study evaluating the safety, tolerability, and preliminary clinical signals of ONP-002 in patients presenting with acute concussion and mild ...
NPR's Scott Detrow talks with Paralympic athlete Oksana Masters about her experiences at this year's Games in Italy.